OXYTOCIC PHARMACEUTICALS MARKET ANALYSIS

Oxytocic Pharmaceuticals Market, By Indication (Abortion Induced Incomplete, Inevitable Abortion, Postpartum Hemorrhage, Labor Induction, and Labor Arrest), By Route of Administration (Intramuscular, and Intravenous Injection/Infusion), By Source of Origin (Synthetic Oxytocin, and Natural Oxytocin (Animal Pituitary Extract)), By End User (Hospitals, and Maternity Clinics), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East and Africa)

Published In : Jun 2023
Code : CMI3354
Pages :160
Formats :
Excel and PDF
Industry : Pharmaceutical

Market Challenges And Opportunities

Problems with oxytocin preparations quality
Accessibility of substitute medications

Global Oxytocic Pharmaceuticals Market: Restraint

Problems with oxytocin preparations quality

Injectable oxytocin, given intravenously or intramuscularly, is recommended by the World Health Organization (WHO) as the first-line medicine for the prevention and treatment of postpartum haemorrhage. It is additionally used for the induction and augmentation of labour. Primary causes for substandard oxytocin quality are considered to be poor-quality manufacturing and/or product degradation in the supply chain. For instance, according to WHO (World Health Organization), 2021 report of Regulatory guidance for assessment and management of applications for marketing authorization of oxytocin, suggested the precautionary measures to be taken related to the supply chain, manufacturing and product degradation of Oxytocic pharmaceuticals. The causes of the issue with oxytocin preparations were also noted by the WHO.